Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer’s disease via estrogen receptor independent pathways

Acta Medica Iranica

Volumn 54, Issue 4, 2016, Pages 245-250

  Sohanaki, Hamid ^a,b   Baluchnejadmojarad, Tourandokht ^b   Nikbakht, Farnaz ^b   Roghani, Mehrdad ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Alzheimer s disease; Estrogen receptor; Hippocampus; Memory dysfunction; Passive avoidance test; Pelargonidin

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ANTIESTROGEN; DIMETHYL SULFOXIDE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ANTAGONIST; KETAMINE; PELARGONIDIN; POVIDONE IODINE; SODIUM CHLORIDE; XYLAZINE; AMYLOID BETA PROTEIN; ANTHOCYANIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INITIAL LATENCY; LATENT PERIOD; MALE; MEMORY DISORDER; MEMORY DYSFUNCTION; NONHUMAN; PASSIVE AVOIDANCE TEST; RAT; STEREOTAXIC SURGERY; ANIMAL; AVOIDANCE BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MEMORY; METABOLISM; TASK PERFORMANCE; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTHOCYANINS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MEMORY; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; TASK PERFORMANCE AND ANALYSIS;

EID: 84964288732     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alzheimer’s A. 2015 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 2015;11(3):332.
2. Querfurth HW, LaFerla FM. Alzheimer’s Disease. New England Journal of Medicine 2010;362(4):329-44
3. Bernal-Mondragon C, Rivas-Arancibia S, Kendrick KM, et al. Estradiol prevents olfactory dysfunction induced by A-beta 25-35 injection in hippocampus. BMC Neurosci 2013;14:104.
4. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 1991;12(10):383-8.
5. Kumar A, Singh A, Ekavali. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 2015;67(2):195-203.
6. Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer’s disease: Past, present and future. Neuropharmacology 2014;76:27-50.
7. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256(5054):184
8. Krstic D, Knuesel I. The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer’s disease. Acta Neuropathol Commun 2013;1:62.
9. Burke A, Hall GR, Yaari R, et al. Pharmacological Treatment of Cognitive Decline in Alzheimer’s Disease. Pocket Reference to Alzheimer’s Disease Management: Springer; 2015. p. 35-40.
10. Dreiseitel A, Schreier P, Oehme A, et al. Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem Biophys Res Commun 2008;372(1):57-61.
11. Paixão J, Dinis TC, Almeida LM. Dietary anthocyanins protect endothelial cells against peroxynitrite-induced mitochondrial apoptosis pathway and Bax nuclear translocation: an in vitro approach. Apoptosis 2011;16(10):976-89.
12. Bowen-Forbes CS, Zhang Y, Nair MG. Anthocyanin content, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits. Journal of Food Composition and Analysis 2010;23(6):554-60.
13. Shindo M, Kasai T, Abe A, et al. Effects of dietary administration of plant-derived anthocyanin-rich colors to spontaneously hypertensive rats. Journal of nutritional science and vitaminology 2007;53(1):90-3.
14. Asgary S, RafieianKopaei M, Sahebkar A, et al. Anti hyperglycemic and anti hyperlipidemic effects of Vaccinium myrtillus fruit in experimentally induced diabetes (antidiabetic effect of Vaccinium myrtillus fruit). Journal of the Science of Food and Agriculture 2015.
15. Nabavi S, Habtemariam S, Daglia M, et al. Anthocyanins as a potential therapy for diabetic retinopathy. Curr Med Chem 2015;22(1):51-8.
16. Kamiloglu S, Capanoglu E, Grootaert C, et al. Anthocyanin Absorption and Metabolism by Human Intestinal Caco-2 Cells-A Review. International journal of molecular sciences 2015;16(9):21555-74.
17. Carkeet C, Clevidence BA, Novotny JA. Anthocyanin excretion by humans increases linearly with increasing strawberry dose. The Journal of nutrition 2008;138(5):897-902.
18. Spencer JP. Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proceedings of the Nutrition Society 2008;67(02):238-52.
19. Abraham SK, Schupp N, Schmid U, et al. Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the polyphenol chlorogenic acid. Molecular nutrition & food research 2007;51(7):880-7.
20. Roghani M, Niknam A, Jalali-Nadoushan MR, et al. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. Brain research bulletin 2010;82(5):279-83.
21. Mirshekar M, Roghani M, Khalili M, et al. Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress. Iranian Biomedical Journal 2010;14(1-2):33.
22. Rechner AR, Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thrombosis research 2005;116(4):327-34.
23. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition: Elsevier Science & Technology Books; 2007.
24. Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biology of reproduction 2002;67(5):1379-85.
25. Chakrabarti M, Haque A, Banik NL, et al. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull 2014;109C:22-31.
26. Jefremov V, Rakitin A, Mahlapuu R, et al. 17β Oestradiol Stimulation of G Proteins in Aged and Alzheimer’s Human Brain: Comparison with Phytoestrogens. Journal of neuroendocrinology 2008;20(5):587-96.
27. Spencer JP, Vafeiadou K, Williams RJ, et al. Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med 2012;33(1):83-97.
28. Hidalgo M, Martin-Santamaria S, Recio I, et al. Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes & nutrition 2012:1-12.
29. Hämäläinen M, Nieminen R, Vuorela P, et al. Anti- inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κ B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κ B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of inflammation 2007;2007.
30. Kruger MJ, Davies N, Myburgh KH, et al. Proanthocyanidins, anthocyanins and cardiovascular diseases. Food Research International 2014;59:41-52.
31. Spencer JP, Crozier A. Flavonoids and related compounds: Bioavailability and Function: CRC Press; 2012.
32. Fader AJ, Johnson PE, Dohanich GP. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine on a radial-arm maze. Pharmacology Biochemistry and Behavior 1999;62(4):711-7.
33. Williams RJ, Spencer JP. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radical Biology and Medicine 2012;52(1):35-45.